Collegium Pharmaceutical, Inc. COLL Deferred Taxes
Deferred Taxes at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s deferred taxes?
- Collegium Pharmaceutical, Inc. (COLL) reported deferred taxes of -$968K in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s deferred taxes changed year-over-year?
- Collegium Pharmaceutical, Inc.'s deferred taxes decreased by 79.6% year-over-year, from -$539K to -$968K.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s deferred taxes?
- Over 3 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s deferred taxes has grown at a -31.0% compound annual growth rate (CAGR), from -$78.04M to -$25.66M.
- What does deferred taxes mean?
- Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.